The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Traveler's Diarrhea Therapeutics Market Research Report 2025
Synopsis
The global market for Traveler's Diarrhea Therapeutics was valued at US$ 900 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Traveler"s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler"s Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Traveler's Diarrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler's Diarrhea Therapeutics.
The Traveler's Diarrhea Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler's Diarrhea Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Traveler's Diarrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Traveler's Diarrhea Therapeutics was valued at US$ 900 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Traveler"s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler"s Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Traveler's Diarrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler's Diarrhea Therapeutics.
The Traveler's Diarrhea Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler's Diarrhea Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Traveler's Diarrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Traveler's Diarrhea Therapeutics Market Overview
1.1 Product Definition
1.2 Traveler's Diarrhea Therapeutics by Type
1.2.1 Global Traveler's Diarrhea Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Others
1.3 Traveler's Diarrhea Therapeutics by Application
1.3.1 Global Traveler's Diarrhea Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 Adult Traveler's Diarrhea
1.3.3 Children Traveler's Diarrhea
1.4 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Traveler's Diarrhea Therapeutics Revenue 2020-2031
1.4.2 Global Traveler's Diarrhea Therapeutics Sales 2020-2031
1.4.3 Global Traveler's Diarrhea Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Traveler's Diarrhea Therapeutics Market Competition by Manufacturers
2.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Traveler's Diarrhea Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Traveler's Diarrhea Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Date of Enter into This Industry
2.8 Global Traveler's Diarrhea Therapeutics Market Competitive Situation and Trends
2.8.1 Global Traveler's Diarrhea Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Traveler's Diarrhea Therapeutics Players Market Share by Revenue
2.8.3 Global Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Traveler's Diarrhea Therapeutics Market Scenario by Region
3.1 Global Traveler's Diarrhea Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2020-2031
3.2.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2020-2025
3.2.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2026-2031
3.3 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2026-2031
3.4 North America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.4.1 North America Traveler's Diarrhea Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
3.4.3 North America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.5.1 Europe Traveler's Diarrhea Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Traveler's Diarrhea Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Traveler's Diarrhea Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2020-2031)
4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
4.1.2 Global Traveler's Diarrhea Therapeutics Sales by Type (2026-2031)
4.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Traveler's Diarrhea Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2020-2031)
5.1.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
5.1.2 Global Traveler's Diarrhea Therapeutics Sales by Application (2026-2031)
5.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Traveler's Diarrhea Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Salix Pharmaceuticals
6.1.1 Salix Pharmaceuticals Company Information
6.1.2 Salix Pharmaceuticals Description and Business Overview
6.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio
6.1.5 Salix Pharmaceuticals Recent Developments/Updates
6.2 P&G
6.2.1 P&G Company Information
6.2.2 P&G Description and Business Overview
6.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio
6.2.5 P&G Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Otsuka Pharma
6.4.1 Otsuka Pharma Company Information
6.4.2 Otsuka Pharma Description and Business Overview
6.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio
6.4.5 Otsuka Pharma Recent Developments/Updates
6.5 Valneva
6.5.1 Valneva Company Information
6.5.2 Valneva Description and Business Overview
6.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio
6.5.5 Valneva Recent Developments/Updates
6.6 Shanghai United Cell
6.6.1 Shanghai United Cell Company Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio
6.6.5 Shanghai United Cell Recent Developments/Updates
6.7 PaxVax
6.7.1 PaxVax Company Information
6.7.2 PaxVax Description and Business Overview
6.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio
6.7.5 PaxVax Recent Developments/Updates
6.8 Livzon
6.8.1 Livzon Company Information
6.8.2 Livzon Description and Business Overview
6.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio
6.8.5 Livzon Recent Developments/Updates
6.9 Immuron
6.9.1 Immuron Company Information
6.9.2 Immuron Description and Business Overview
6.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio
6.9.5 Immuron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Traveler's Diarrhea Therapeutics Industry Chain Analysis
7.2 Traveler's Diarrhea Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Traveler's Diarrhea Therapeutics Production Mode & Process Analysis
7.4 Traveler's Diarrhea Therapeutics Sales and Marketing
7.4.1 Traveler's Diarrhea Therapeutics Sales Channels
7.4.2 Traveler's Diarrhea Therapeutics Distributors
7.5 Traveler's Diarrhea Therapeutics Customer Analysis
8 Traveler's Diarrhea Therapeutics Market Dynamics
8.1 Traveler's Diarrhea Therapeutics Industry Trends
8.2 Traveler's Diarrhea Therapeutics Market Drivers
8.3 Traveler's Diarrhea Therapeutics Market Challenges
8.4 Traveler's Diarrhea Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Traveler's Diarrhea Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Traveler's Diarrhea Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Traveler's Diarrhea Therapeutics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Traveler's Diarrhea Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Traveler's Diarrhea Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Traveler's Diarrhea Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Traveler's Diarrhea Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Traveler's Diarrhea Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Traveler's Diarrhea Therapeutics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Traveler's Diarrhea Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Traveler's Diarrhea Therapeutics Sales by Region (2020-2025) & (K Units)
Table 18. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2020-2025)
Table 19. Global Traveler's Diarrhea Therapeutics Sales by Region (2026-2031) & (K Units)
Table 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2026-2031)
Table 21. Global Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2020-2025)
Table 23. Global Traveler's Diarrhea Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2026-2031)
Table 25. North America Traveler's Diarrhea Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
Table 27. North America Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
Table 28. North America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Traveler's Diarrhea Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Traveler's Diarrhea Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2020-2025)
Table 51. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2026-2031)
Table 52. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
Table 53. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2026-2031)
Table 54. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2020-2025)
Table 57. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2026-2031)
Table 58. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 59. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2026-2031)
Table 60. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2020-2025)
Table 61. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2026-2031)
Table 62. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2020-2025)
Table 63. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2026-2031)
Table 64. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2020-2025)
Table 67. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2026-2031)
Table 68. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2020-2025)
Table 69. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2026-2031)
Table 70. Salix Pharmaceuticals Company Information
Table 71. Salix Pharmaceuticals Description and Business Overview
Table 72. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product
Table 74. Salix Pharmaceuticals Recent Developments/Updates
Table 75. P&G Company Information
Table 76. P&G Description and Business Overview
Table 77. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. P&G Traveler's Diarrhea Therapeutics Product
Table 79. P&G Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Traveler's Diarrhea Therapeutics Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Otsuka Pharma Company Information
Table 86. Otsuka Pharma Description and Business Overview
Table 87. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Otsuka Pharma Traveler's Diarrhea Therapeutics Product
Table 89. Otsuka Pharma Recent Developments/Updates
Table 90. Valneva Company Information
Table 91. Valneva Description and Business Overview
Table 92. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Valneva Traveler's Diarrhea Therapeutics Product
Table 94. Valneva Recent Developments/Updates
Table 95. Shanghai United Cell Company Information
Table 96. Shanghai United Cell Description and Business Overview
Table 97. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Shanghai United Cell Traveler's Diarrhea Therapeutics Product
Table 99. Shanghai United Cell Recent Developments/Updates
Table 100. PaxVax Company Information
Table 101. PaxVax Description and Business Overview
Table 102. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. PaxVax Traveler's Diarrhea Therapeutics Product
Table 104. PaxVax Recent Developments/Updates
Table 105. Livzon Company Information
Table 106. Livzon Description and Business Overview
Table 107. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Livzon Traveler's Diarrhea Therapeutics Product
Table 109. Livzon Recent Developments/Updates
Table 110. Immuron Company Information
Table 111. Immuron Description and Business Overview
Table 112. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Immuron Traveler's Diarrhea Therapeutics Product
Table 114. Immuron Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Traveler's Diarrhea Therapeutics Distributors List
Table 118. Traveler's Diarrhea Therapeutics Customers List
Table 119. Traveler's Diarrhea Therapeutics Market Trends
Table 120. Traveler's Diarrhea Therapeutics Market Drivers
Table 121. Traveler's Diarrhea Therapeutics Market Challenges
Table 122. Traveler's Diarrhea Therapeutics Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Traveler's Diarrhea Therapeutics
Figure 2. Global Traveler's Diarrhea Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Traveler's Diarrhea Therapeutics Market Share by Type: 2024 & 2031
Figure 4. Immunization Product Picture
Figure 5. Non-antibiotic Agents Product Picture
Figure 6. Antibiotics Product Picture
Figure 7. Anti-Motility Agents Product Picture
Figure 8. Others Product Picture
Figure 9. Global Traveler's Diarrhea Therapeutics Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Traveler's Diarrhea Therapeutics Market Share by Application: 2024 & 2031
Figure 11. Adult Traveler's Diarrhea
Figure 12. Children Traveler's Diarrhea
Figure 13. Global Traveler's Diarrhea Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Traveler's Diarrhea Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Traveler's Diarrhea Therapeutics Sales (2020-2031) & (K Units)
Figure 16. Global Traveler's Diarrhea Therapeutics Average Price (USD/Unit) & (2020-2031)
Figure 17. Traveler's Diarrhea Therapeutics Report Years Considered
Figure 18. Traveler's Diarrhea Therapeutics Sales Share by Manufacturers in 2024
Figure 19. Global Traveler's Diarrhea Therapeutics Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Traveler's Diarrhea Therapeutics Players: Market Share by Revenue in Traveler's Diarrhea Therapeutics in 2024
Figure 21. Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Traveler's Diarrhea Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
Figure 24. North America Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
Figure 28. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
Figure 29. Germany Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2020-2031)
Figure 36. China Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Traveler's Diarrhea Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Traveler's Diarrhea Therapeutics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Traveler's Diarrhea Therapeutics by Type (2020-2031)
Figure 57. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Traveler's Diarrhea Therapeutics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Traveler's Diarrhea Therapeutics by Application (2020-2031)
Figure 60. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2020-2031)
Figure 61. Traveler's Diarrhea Therapeutics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
